The COVID Vaccine Mandate Quandary

Authoritative Information For Informed Decisions in a Re-shaped Workplace

With numerous vaccines becoming available, a re-opening of many of our organizations is in sight. As we consider our “new normal,” business leaders are faced with challenges presented by the societal shifts caused by COVID-19.

How to safely navigate re-opening our workplaces is fraught with considerations both from a health safety and legal standpoint. Until now, finding valid and authoritative sources of information has been difficult for employers. This webinar addresses the most pressing issues facing organizational leaders, including:

  • Understanding the various leading COVID-19 vaccines, including safety and efficacy
  • Misperceptions associated with vaccination
  • Frameworks for a safe return to work for your employees
  • Legal perspectives on the factors and exceptions to consider when determining whether to mandate vaccinations
  • Strategies to encourage employees to get vaccinated.


This nuanced and multi-faceted issue is brought into focus by presenters known to be leaders in medicine as well as employment law. Their combined knowledge will prepare you to make informed decisions whether you have employees currently at the workplace or if you are just now planning for future return to work dates.


At many of the PSA Insurance and Financial Services’ (“PSA”) partnership seminars and events, we and our guest speakers photograph and record the events and attendees for use in future marketing and other materials. Accordingly, by registering for and/or attending PSA partnership seminars and events, you hereby authorize PSA and any speaker at such events, and their respective affiliates, successors, and assigns (each an “Authorized Person”), to photograph and record your name, likeness, image, voice and other features on film, tape, or otherwise (a “recording”), edit such recording as such Authorized Person may desire, and incorporate such recording into print, videos, films, and other printed and electronic media, and all related materials thereof, including, without limitation, promotion and advertising materials (each a “bi-product”). It is understood and agreed that each Authorized Person shall retain final editorial, artistic and technical control of the bi-product and the content thereof. Each Authorized Person may use the bi-products, any portions thereof and the recordings in all markets, manner, formats and media, whether now known or hereafter developed, through the world, in perpetuity. Each Authorized person shall own all right, title and interest, including the copyright, in and to its bi-product and related materials, to be used and disposed of, without limitation, as such Authorized Person may determine in its sole and absolute discretion.